What do systematic reviews say?

Rituximab vs placebo or control

Rituximab showed no clear difference in adverse effects: severe infection compared with placebo or control (low certainty).

• Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 0.9 [0.26, 3.15]
  3 studies · 222 participants
  Low